Cognoptix
Signal active
Organization
Contact Information
Overview
Cognoptix is creating and developing an innovative, non-invasive eye test to assist in the early diagnosis of Alzheimer's Disease. Cognoptix's goal is to provide clinicians with a quick, predictive, reliable, inexpensive, and widely available test, enabling early diagnosis and treatment.
The company was founded in 2001 and headquartered in Marlborough, Massachusetts.
About
Industries
Biotechnology, Health Care, Medical Device, Therapeutics, Health Diagnostics
Founded
2001
Employees
1-10
Headquarters locations
United States, North America
Social
N/A
Profile Resume
Cognoptix headquartered in United States, North America, operates in the Biotechnology, Health Care, Medical Device, Therapeutics, Health Diagnostics sector. The company focuses on Biotechnology and has secured $9.3B in funding across 200 round(s). With a team of 1-10 employees, Cognoptix is actively contributing to advancements in Biotechnology. Their latest funding round, Series C - Cognoptix, raised $4.6M. Discover more about their projects, partnerships, and impact on our platform.
Funding Rounds
Funding rounds
10
Investors
0
Lead Investors
0
Total Funding Amount
$46.3M
Details
6
Cognoptix has raised a total of $46.3M in funding over 6 rounds.
| Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
|---|---|---|---|---|
| 2008 | Early Stage Venture | 18.5M | ||
| 2008 | Early Stage Venture | 849.0K | ||
| 2014 | Late Stage Venture | 15.0M | ||
| 2011 | Late Stage Venture | 4.6M |
Investors
Cognoptix is funded by 26 investors.
| Investor Name | Lead Investor | Funding Round | Partners |
|---|---|---|---|
| Cognoptix | - | FUNDING ROUND - Cognoptix | 18.5M |
| Rockport Venture Partners | - | FUNDING ROUND - Rockport Venture Partners | 18.5M |
| Cognoptix | - | FUNDING ROUND - Cognoptix | 390.0K |
| Maine Angels | - | FUNDING ROUND - Maine Angels | 390.0K |
Recent Activity
There is no recent news or activity for this profile.